Business, share and intangible valuations that satisfy Indian regulatory requirements while standing up to the reporting expectations of a US-based parent, investor or counterparty — delivered by partners holding IBBI Registered Valuer credentials.
Valuation is rarely a single-jurisdiction exercise for the companies we serve. An ESOP valuation for an India subsidiary may need to satisfy Indian Income Tax Act requirements and the equity compensation reporting standards of a US-listed parent. A share transfer between group entities needs to be defensible under FEMA pricing guidelines and support the purchase price allocation in the acquirer's US GAAP or IFRS financial statements.
Our valuation practice — led by partners holding IBBI Registered Valuer credentials with 200+ completed valuations — is built to produce a single valuation deliverable that holds up on both sides of that line.
Indian regulations prescribe specific valuation methodologies and reporting formats depending on the purpose — a share issue to a non-resident, for instance, has different requirements under FEMA than a valuation for income tax purposes under Section 56(2)(viib) or Rule 11UA.
Our India valuation practice is led by registered valuers under the IBBI framework, ensuring valuations carry the regulatory standing required for company law, tax, and FEMA filings.
For India subsidiaries of US companies, or Indian companies with US-based investors or cap tables, valuations often need to satisfy US equity compensation and financial reporting standards in addition to Indian requirements.
We coordinate valuation methodology and documentation so the output is usable for both the Indian filing requirement and the US-side reporting need — avoiding duplicate valuation exercises run by separate, uncoordinated advisors.
Every valuation report we issue is built to withstand scrutiny — whether from a tax assessing officer, a statutory auditor, or a global audit team reviewing the parent company's consolidated accounts. We document the methodology selected (DCF, comparable companies, comparable transactions, NAV, or a combination), the key assumptions, and the sensitivity of the conclusion to those assumptions.